Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

Novo spends $800m to buy biotech and ‘glucose responsive insulin’ tech

Ziylo could help it stay ahead in key insulin franchise

- PMLiVE

Regeneron and Teva close gap on rivals with NGF pain drug

Fasinumab was associated with less pain and improved functional ability compared to placebo

- PMLiVE

Pfizer signs mRNA flu vaccine deal with BioNTech

Pharma giant will take on development and commercial responsibility for candidates

- PMLiVE

Daily Brief: Summit’s $12m lifeline, Biohaven’s speech anxiety pill, Crescendo’s Humabody progress

News from pharma, biotech and healthcare

- PMLiVE

US insurers can peg access to ICER value reviews

Latest step in US pricing evolution

- PMLiVE

Burson Cohn & Wolfe acquires Hirshorn Zuckerman

And CEO Zuckerman will become COO

- PMLiVE

Healthcare Comms appointments

Andrew Martello joins imc, bmore adds to team and ARK gets a new director

If you’re not thinking segmentation, you’re not thinking

Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...

Page & Page Health

- PMLiVE

ViiV chalks up another win for two-drug HIV regimen

Once a month injection matches triple oral therapy

- PMLiVE

Daily Brief: another departure at Gilead, veteran researcher to head up Karuna

Exodus continues from Gilead

- PMLiVE

Anti-ageing gets another boost with Napa Therapeutics launch

Juvenescence teams up with Insilico Medicines and Buck Institute

- PMLiVE

Industry appointments

Vivaldi heads up Sigilon, Pfizer Oncology loses its CMO and Zelluna appoints new CSO

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links